Your browser doesn't support javascript.
loading
Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC.
Belderbos, R A; Corneth, O B J; Dumoulin, D; Hendriks, R W; Aerts, J G J V; Willemsen, M.
Affiliation
  • Belderbos RA; Department of Pulmonary Medicine, the Netherlands; Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, the Netherlands. Electronic address: r.belderbos@erasmusmc.nl.
  • Corneth OBJ; Department of Pulmonary Medicine, the Netherlands.
  • Dumoulin D; Department of Pulmonary Medicine, the Netherlands; Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, the Netherlands.
  • Hendriks RW; Department of Pulmonary Medicine, the Netherlands.
  • Aerts JGJV; Department of Pulmonary Medicine, the Netherlands; Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, the Netherlands. Electronic address: j.aerts@erasmusmc.nl.
  • Willemsen M; Department of Pulmonary Medicine, the Netherlands; Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, the Netherlands.
Eur J Cancer ; 196: 113428, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38039777
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Mesothelioma Limits: Humans Language: En Journal: Eur J Cancer Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Mesothelioma Limits: Humans Language: En Journal: Eur J Cancer Year: 2024 Document type: Article